159 related articles for article (PubMed ID: 35001425)
61. Primary Cutaneous CD8(+) CD30(+) Anaplastic Large Cell Lymphoma: An Unusual Case with a High Ki-67 index-A Short Review.
Nasit JG; Patel SC
Indian J Dermatol; 2015; 60(4):373-7. PubMed ID: 26288406
[TBL] [Abstract][Full Text] [Related]
62. Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma.
Eberle FC; Song JY; Xi L; Raffeld M; Harris NL; Wilson WH; Pittaluga S; Jaffe ES
Am J Surg Pathol; 2012 May; 36(5):716-25. PubMed ID: 22367293
[TBL] [Abstract][Full Text] [Related]
63. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part II: Prognosis and management.
Oh Y; Stoll JR; Moskowitz A; Pulitzer M; Horwitz S; Myskowski P; Noor SJ
J Am Acad Dermatol; 2021 Nov; 85(5):1093-1106. PubMed ID: 33945836
[TBL] [Abstract][Full Text] [Related]
64. Recurrent course and CD30 expression of atypical T lymphocytes distinguish lymphomatoid papulosis from primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma.
Tsujiwaki M; Abe R; Ohguchi Y; Hoshina D; Murata J; Fujita Y; Nomura T; Ambo M; Shimizu H
Acta Derm Venereol; 2014 Sep; 94(5):613-4. PubMed ID: 24549273
[No Abstract] [Full Text] [Related]
65. Practical Management of CD30⁺ Lymphoproliferative Disorders.
Hughey LC
Dermatol Clin; 2015 Oct; 33(4):819-33. PubMed ID: 26433852
[TBL] [Abstract][Full Text] [Related]
66. Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma.
Gill RPK; Gantchev J; Martínez Villarreal A; Ramchatesingh B; Netchiporouk E; Akilov OE; Ødum N; Gniadecki R; Koralov SB; Litvinov IV
Cells; 2022 Feb; 11(4):. PubMed ID: 35203244
[TBL] [Abstract][Full Text] [Related]
67. [Cutaneous CD8+ epidermotropic cytotoxic T-cell lymphoma with aggressive course].
Poszepczynska-Guigné E; Jagou M; Wechsler J; Dieng MT; Revuz J; Bagot M
Ann Dermatol Venereol; 2006 Mar; 133(3):253-6. PubMed ID: 16800177
[TBL] [Abstract][Full Text] [Related]
68. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
Paulli M; Berti E
Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
[TBL] [Abstract][Full Text] [Related]
69. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.
Santucci M; Pimpinelli N; Massi D; Kadin ME; Meijer CJ; Müller-Hermelink HK; Paulli M; Wechsler J; Willemze R; Audring H; Bernengo MG; Cerroni L; Chimenti S; Chott A; Díaz-Pérez JL; Dippel E; Duncan LM; Feller AC; Geerts ML; Hallermann C; Kempf W; Russell-Jones R; Sander C; Berti E;
Cancer; 2003 Feb; 97(3):610-27. PubMed ID: 12548603
[TBL] [Abstract][Full Text] [Related]
70. Lymphomatoid papulosis histopathologically simulating angiocentric and cytotoxic T-cell lymphoma: a case report.
Wu WM; Tsai HJ
Am J Dermatopathol; 2004 Apr; 26(2):133-5. PubMed ID: 15024196
[TBL] [Abstract][Full Text] [Related]
71. Primary cutaneous peripheral T-cell lymphoma with a late relapse solely in the ileum mimicking monomorphic epitheliotropic intestinal T-cell lymphoma.
Pan ST; Ko YH; Tan SY; Chuang SS
Pathol Res Pract; 2018 Dec; 214(12):2106-2109. PubMed ID: 30477646
[TBL] [Abstract][Full Text] [Related]
72. Unusual CD8 positive lymphomatoid papulosis in childhood.
Mateo S; Vázquez Osorio I; José Seoane M; Manuel Súarez-Peñaranda J; Vázquez Veiga H
Dermatol Online J; 2014 Nov; 20(11):. PubMed ID: 25419749
[TBL] [Abstract][Full Text] [Related]
73. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma with a CD15(+)CD30(-) phenotype.
Yoshizawa N; Yagi H; Horibe T; Takigawa M; Sugiura M
Eur J Dermatol; 2007; 17(5):441-2. PubMed ID: 17673391
[TBL] [Abstract][Full Text] [Related]
74. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
[TBL] [Abstract][Full Text] [Related]
75. Hydroa vacciniforme-like lymphoma: a case report from India.
Boddu D; George R; Nair S; Bindra M; G Mathew L
J Pediatr Hematol Oncol; 2015 May; 37(4):e223-6. PubMed ID: 25072366
[TBL] [Abstract][Full Text] [Related]
76. Cutaneous lymphomas other than mycosis fungoides in Singapore: a clinicopathological analysis using recent classification systems.
Tan SH; Sim CS; Ong BH
Br J Dermatol; 2003 Sep; 149(3):542-53. PubMed ID: 14510987
[TBL] [Abstract][Full Text] [Related]
77. Immunophenotypic shift of CD4 and CD8 antigen expression in primary cutaneous T-cell lymphomas: a clinicopathologic study of three cases.
Aung PP; Climent F; Muzzafar T; Curry JL; Patel KP; Servitje O; Prieto VG; Duvic M; Jaffe ES; Torres-Cabala CA
J Cutan Pathol; 2014 Jan; 41(1):51-7. PubMed ID: 24151865
[TBL] [Abstract][Full Text] [Related]
78. Hydroa vacciniforme-like lymphoma with primarily periorbital swelling: 7 cases of an atypical clinical manifestation of this rare cutaneous T-cell lymphoma.
Plaza JA; Sangueza M
Am J Dermatopathol; 2015 Jan; 37(1):20-5. PubMed ID: 25162933
[TBL] [Abstract][Full Text] [Related]
79. Vulvar Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma.
Morse DC; Park KE; Chitsazzadeh V; Li S; Young K; Gunther JR; Dabaja BS; Duvic M
Int J Gynecol Pathol; 2021 May; 40(3):229-233. PubMed ID: 33741766
[TBL] [Abstract][Full Text] [Related]
80. Fatal CD8+ epidermotropic cytotoxic primary cutaneous T-cell lymphoma with multiorgan involvement.
Marzano AV; Ghislanzoni M; Gianelli U; Caputo R; Alessi E; Berti E
Dermatology; 2005; 211(3):281-5. PubMed ID: 16205076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
